头颈部鳞状细胞癌 CAR-T 细胞治疗的进展与挑战
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma.
67.8分
★★★☆☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 7
条件筛选 · 已选 3 项 · 共 7 条展开收起
CRISPR/Cas9 TCR 编辑的 NKp30 CAR-T 细胞对表达 B7H6 的白血病与黑色素瘤表现出更强的抗肿瘤免疫
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.
55.1分
★★★☆☆
站内排序·非疗效
在 BCMA-CART 细胞治疗背景下 TIGIT 阻断未能在多发性骨髓瘤小鼠模型中增强疗效
TIGIT blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model.
53.6分
★★★☆☆
站内排序·非疗效
Blimp-1 基因敲除显著增强靶向 BCMA 的 CAR-T 细胞抗肿瘤疗效
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells.
50.6分
★★★☆☆
站内排序·非疗效
靶向 CD38 与 SLAMF7、具有独立信号传导的双 CAR-T 细胞在多发性骨髓瘤中显示临床前疗效与安全性
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple My
48.0分
★★★☆☆
站内排序·非疗效
当前抗骨髓瘤 CAR-T 细胞：新型靶点与方法
Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods.
38.0分
★★☆☆☆
站内排序·非疗效
浆细胞疾病细胞免疫治疗的 2025 年更新
2025 Update of Cellular Immunotherapy for Plasma Cell Disorders.
28.4分
★☆☆☆☆
站内排序·非疗效
共 7 条